Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Current Topics in Medicinal Chemistry|June 12, 2010
Discovery of 3,4-diaminocyclobut-3-ene-1,2-dione-based CXCR2 receptor antagonists for the treatment of inflammatory disordersMichael P Dwyer, Purakattle BijuExpert Opinion on Therapeutic Patents|February 22, 2014
CXCR2 modulators: a patent review (2009 - 2013)Michael P Dwyer, Younong YuCurrent Topics in Medicinal Chemistry|August 28, 2014
CXCR2 receptor antagonists: a medicinal chemistry perspectiveMichael P Dwyer, Younong YuBioorganic & Medicinal Chemistry Letters|February 7, 2009
Fluoroalkyl alpha side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2-CXCR1 dual antagonistsPurakkattle Biju, Arthur G Taveras, Michael P Dwyer, et al.Bioorganic & Medicinal Chemistry Letters|October 5, 2013
Discovery of pyrazolo[1,5-a]pyrimidine-based Pim inhibitors: a template-based approachMichael P Dwyer, Kartik Keertikar, Kamil Paruch, et al.Bioorganic & Medicinal Chemistry Letters|November 25, 2010
Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 2Marc Labroli, Kamil Paruch, Michael P Dwyer, et al.Bioorganic & Medicinal Chemistry Letters|May 16, 2006
Synthesis and structure-activity relationships of 3,4-diaminocyclobut-3-ene-1,2-dione CXCR2 antagonistsJ Robert Merritt, Laura L Rokosz, Kingsley H Nelson, et al.Bioorganic & Medicinal Chemistry Letters|November 25, 2010
Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: a template-based approach--part 1Michael P Dwyer, Kamil Paruch, Marc Labroli, et al.Bioorganic & Medicinal Chemistry Letters|May 15, 2021
Discovery of novel N-1 substituted pyrazolopyrimidinones as potent, selective PDE2 inhibitorsGregori J Morriello, Michael P Dwyer, Yili Chen, et al.Molecular Cancer Therapeutics|February 16, 2011
Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screeningTimothy J Guzi, Kamil Paruch, Michael P Dwyer, et al.Pageof 4